middle.news
Race Oncology Secures Ethics Nod for Pioneering Lung Cancer Trial
9:38am on Wednesday 26th of November, 2025 AEDT
•
Healthcare
Read Story
Race Oncology Secures Ethics Nod for Pioneering Lung Cancer Trial
9:38am on Wednesday 26th of November, 2025 AEDT
Key Points
Human ethics approval granted by St Vincents Hospital Melbourne
Phase 1a/b trial to evaluate RC220 with osimertinib in EGFR-mutated NSCLC
Patient enrolment to begin late Q4 2025 or early Q1 2026 at Monash Health
Trial uses Bayesian design to identify maximum tolerated dose of RC220
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Racura Oncology (ASX:RAC)
OPEN ARTICLE